Nevro Corp (NASDAQ:NVRO) VP Michael Enxing sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, October 4th. The stock was sold at an average price of $99.31, for a total value of $148,965.00. Following the sale, the vice president now directly owns 39,463 shares in the company, valued at $3,919,070.53. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Michael Enxing also recently made the following trade(s):

  • On Thursday, August 4th, Michael Enxing sold 1,500 shares of Nevro Corp stock. The stock was sold at an average price of $82.06, for a total value of $123,090.00.

Nevro Corp (NASDAQ:NVRO) opened at 94.15 on Monday. Nevro Corp has a 52 week low of $36.51 and a 52 week high of $106.93. The company has a 50-day moving average price of $97.65 and a 200 day moving average price of $78.56. The company’s market cap is $2.68 billion.

Nevro Corp (NASDAQ:NVRO) last issued its quarterly earnings results on Monday, August 8th. The company reported ($0.31) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.47) by $0.16. The company earned $55.40 million during the quarter, compared to analysts’ expectations of $45.11 million. The firm’s revenue was up 385.5% on a year-over-year basis. On average, equities research analysts forecast that Nevro Corp will post ($1.42) EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Nevro Corp (NASDAQ:NVRO)

Hedge funds and other institutional investors have recently modified their holdings of the stock. Sei Investments Co. raised its position in Nevro Corp by 40.0% in the second quarter. Sei Investments Co. now owns 1,620 shares of the company’s stock worth $119,000 after buying an additional 463 shares during the period. Fortaleza Asset Management Inc. acquired a new position in Nevro Corp during the second quarter worth $125,000. BlackRock Inc. raised its position in Nevro Corp by 130.1% in the second quarter. BlackRock Inc. now owns 2,487 shares of the company’s stock worth $183,000 after buying an additional 1,406 shares during the period. BNP Paribas Arbitrage SA raised its position in Nevro Corp by 110.8% in the third quarter. BNP Paribas Arbitrage SA now owns 1,977 shares of the company’s stock worth $206,000 after buying an additional 1,039 shares during the period. Finally, Numeric Investors LLC acquired a new position in Nevro Corp during the second quarter worth $207,000.

Several equities research analysts have weighed in on NVRO shares. Zacks Investment Research raised Nevro Corp from a “hold” rating to a “buy” rating and set a $110.00 price objective on the stock in a research note on Wednesday, October 5th. Morgan Stanley reaffirmed a “buy” rating and set a $86.00 target price on shares of Nevro Corp in a research note on Wednesday, June 29th. Wells Fargo & Co. assumed coverage on Nevro Corp in a research note on Tuesday, July 12th. They set an “outperform” rating on the stock. William Blair assumed coverage on Nevro Corp in a research note on Tuesday, July 19th. They set an “outperform” rating on the stock. Finally, JMP Securities upped their target price on Nevro Corp from $90.00 to $110.00 and gave the company a “market outperform” rating in a research note on Tuesday, August 9th. Eleven equities research analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and an average target price of $104.00.

About Nevro Corp

Nevro Corp. is a medical device company. The Company has developed and commercialized a neuromodulation platform for the treatment of chronic pain. The Company’s Senza system is a spinal cord stimulation (SCS) system that delivers its HF10 therapy. HF10 therapy is designed to deliver neuromodulation solutions for treating chronic pain.

5 Day Chart for NASDAQ:NVRO

Receive News & Stock Ratings for Nevro Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nevro Corp and related stocks with our FREE daily email newsletter.